CIS-5-OCTENAL
Relevant Data
Food Additives Approved by WHO:
Flavouring Substances Approved by European Union:
General Information
| Mainterm | CIS-5-OCTENAL |
| Doc Type | NIL |
| CAS Reg.No.(or other ID) | 41547-22-2 |
| Regnum |
From www.fda.gov
Computed Descriptors
Download SDF| 2D Structure | |
| CID | 6435869 |
| IUPAC Name | (Z)-oct-5-enal |
| InChI | InChI=1S/C8H14O/c1-2-3-4-5-6-7-8-9/h3-4,8H,2,5-7H2,1H3/b4-3- |
| InChI Key | ZUSUVEKHEZURSD-ARJAWSKDSA-N |
| Canonical SMILES | CCC=CCCCC=O |
| Molecular Formula | C8H14O |
| Wikipedia | (5Z)-5-octenal |
From Pubchem
Computed Properties
| Property Name | Property Value |
|---|---|
| Molecular Weight | 126.199 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 5 |
| Complexity | 84.6 |
| CACTVS Substructure Key Fingerprint | A A A D c c B w I A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A G g A A A A A A C A C g g A I C A A A A A A C I A C h S g A A A A A A g A A A I C A E A A A g A A B I A A Q A A A A A A g A A I A A I I A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
| Topological Polar Surface Area | 17.1 |
| Monoisotopic Mass | 126.104 |
| Exact Mass | 126.104 |
| XLogP3 | None |
| XLogP3-AA | 1.8 |
| Compound Is Canonicalized | True |
| Formal Charge | 0 |
| Heavy Atom Count | 9 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Isotope Atom Count | 0 |
| Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
| Model | Result | Probability |
|---|---|---|
| Absorption | ||
| Blood-Brain Barrier | BBB+ | 0.9781 |
| Human Intestinal Absorption | HIA+ | 0.9957 |
| Caco-2 Permeability | Caco2+ | 0.8262 |
| P-glycoprotein Substrate | Non-substrate | 0.7163 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8540 |
| Non-inhibitor | 0.8338 | |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8916 |
| Distribution | ||
| Subcellular localization | Plasma membrane | 0.5982 |
| Metabolism | ||
| CYP450 2C9 Substrate | Non-substrate | 0.8076 |
| CYP450 2D6 Substrate | Non-substrate | 0.8914 |
| CYP450 3A4 Substrate | Non-substrate | 0.7208 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.6011 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9199 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9697 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9561 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9802 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7659 |
| Excretion | ||
| Toxicity | ||
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.6933 |
| Non-inhibitor | 0.9062 | |
| AMES Toxicity | Non AMES toxic | 0.7937 |
| Carcinogens | Carcinogens | 0.5866 |
| Fish Toxicity | High FHMT | 0.8284 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9976 |
| Honey Bee Toxicity | High HBT | 0.7599 |
| Biodegradation | Not ready biodegradable | 0.5202 |
| Acute Oral Toxicity | III | 0.8647 |
| Carcinogenicity (Three-class) | Non-required | 0.6407 |
From admetSAR
ADMET Predicted Profile --- Regression
| Model | Value | Unit |
|---|---|---|
| Absorption | ||
| Aqueous solubility | -1.9654 | LogS |
| Caco-2 Permeability | 1.3271 | LogPapp, cm/s |
| Distribution | ||
| Metabolism | ||
| Excretion | ||
| Toxicity | ||
| Rat Acute Toxicity | 1.5930 | LD50, mol/kg |
| Fish Toxicity | 0.4247 | pLC50, mg/L |
| Tetrahymena Pyriformis Toxicity | 0.8249 | pIGC50, ug/L |
From admetSAR